Colorado University researchers developing new measles vaccine

A University of Colorado professor and his team of researchers are in the process of developing a new dry measles vaccine that could potentially prevent the deaths of thousands of children in undeveloped countries.

Bob Sievers, a chemistry and biochemistry professor at University of Colorado, is leading a team of researchers who have created the dry measles vaccine. Sievers told that there are approximately 200,000 deaths per year from measles-related illness.

In addition to the dry powder measles vaccine, the research team has also created an inexpensive device, which is similar to an inhaler, which disperses the powder.

“It goes into the lungs, through the throat, through the nose, through a face mask. Within 30 seconds, the vaccination is over," Sievers told "There's no needle punctures, no blood, no pain."

According to the research team, the dry vaccine has several advantages over injection vaccines. It doesn’t have to be refrigerated during transportation and it does not need water to be reconstituted. Most importantly, it will not transmit disease through shared needles.

Pankaj Pathak, an immigrant from Himachal, India and part of the CU research team, explained these advantages.

“In some places, they don't have even power or conditions where you could keep them refrigerated and its one main reason they can't get vaccine,” Pathak told

The vaccine will undergo human clinical trials this summer in India.

Researchers believe the new technology could also be used for influenza and to treat human papillomavirus and tuberculosis.